Sort   by:  
 Page size 
UnknownVaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Not available
S-EPMC11487098 | biostudies-literature
UnknownChanging Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Not available
S-EPMC10526883 | biostudies-literature
UnknownVaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
Not available
S-EPMC9551237 | biostudies-literature
UnknownEffectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
Not available
S-EPMC9113447 | biostudies-literature
UnknownEffectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism.
Not available
S-EPMC12063076 | biostudies-literature
UnknownAbsolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
Not available
S-EPMC9868348 | biostudies-literature
UnknownLowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization.
Not available
S-EPMC10586470 | biostudies-literature
Sort   by:  
 Page size